Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study ; volume:10 ; number:1 ; day:28 ; month:01 ; year:2008 ; pages:1-6 ; date:2.2008
Arthritis Research & Therapy ; 10, Heft 1 (28.01.2008), 1-6, 2.2008
- Creator
-
Ursum, Jennie
- Contributor
-
Nielen, Markus MJ
van Schaardenburg, Dirkjan
van der Horst, Ann R.
van de Stadt, Rob J.
Dijkmans, Ben AC
Hamann, Dörte
SpringerLink (Online service)
- DOI
-
10.1186/ar2362
- URN
-
urn:nbn:de:1111-201605038607
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ursum, Jennie
- Nielen, Markus MJ
- van Schaardenburg, Dirkjan
- van der Horst, Ann R.
- van de Stadt, Rob J.
- Dijkmans, Ben AC
- Hamann, Dörte
- SpringerLink (Online service)
Other Objects (12)
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies